A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. - Graff JN; Smith CEP; Sokolova AO; Qian DZ; Beer TM; Latour E; Bailey S; Kreitner D; Grivas P; Schweizer MT; Higano CS; Alumkal JJ; et al. (The oncologist, 2026)